Australia markets closed

Cadrenal Therapeutics, Inc. (CVKD)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4305+0.0069 (+1.63%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
Cash flows from operating activities
Net income
-8,357
-8,357
Depreciation & amortisation
1.98
1.98
Stock-based compensation
710.381
710.381
Change in working capital
144.309
144.309
Accounts payable
-237.578
-237.578
Other working capital
-3,534
-3,534
Other non-cash items
3,014
3,014
Net cash provided by operating activities
-3,530
-3,530
Cash flows from investing activities
Investments in property, plant and equipment
-3.254
-3.254
Net cash used for investing activities
-3.254
-3.254
Cash flows from financing activities
Debt repayment
-250
-250
Common stock issued
11,903
11,903
Net cash used provided by (used for) financing activities
11,903
11,903
Net change in cash
8,370
8,370
Cash at beginning of period
32.586
32.586
Cash at end of period
8,403
8,403
Free cash flow
Operating cash flow
-3,530
-3,530
Capital expenditure
-3.254
-3.254
Free cash flow
-3,534
-3,534